Two series of bis[2-(E-2-alkenoylamino)ethyl] disulfides (compds. I) and 2-(E-alkenoylamino)ethyl carbamoylmethyl sulfides (compds. II) were synthesized from 2-trans unsaturated fatty acids (Co: i-C14:1) and cystamine, and their effects on carrageenin-induced paw edema were studied. Several of compds. I and II showed significant anti-edema activity at a dose of 25 mg/kg, i.p. These derivatives were much more potent than the starting materials. The alkene chain length influenced the activity. The compounds (compds. 1-3, 1-8, 11-3 and 11-8) with C8:1 and C13,, fatty acids showed the highest activity in both series. Compounds 1-3 and 11-3 with the C8.1 fatty acid were also effective when administered orally at a dose of 10 mg/kg.
Previously, we reported that 2-(E-2-alkenoylamino)ethyl carbamoylmethyl sulfides (compds. II, Table I ) had more potent anti-ulcerogenic activity than the starting materials, various 2-trans unsaturated fatty acids and cysteamine." In this work, the anti-inflammatory activity of compds. II and its disulfide analogues (compds. I, Table I ) was studied by using the carrageenin-induced paw edema model in rats.
Experimental
Materials Cystine, cysteine, cystamine dihydrochloride, cysteamine hydrochloride, methionine, methionine sulfone, methionine sulfate, ethionine and lanthionine were obtained from Nakarai Chemicals, Ltd. The following nine unsaturated fatty acids containing one trans double bond between the 2nd and 3rd carbons were obtainedfrom Tokyo Kasei Co.: trans-2-hexenoic acid (C6:,), trans-2-heptenoic acid (C7:1), trans-2-octenoic acid (C8:1), trans-2-nonenoic acid (C9:1), trans-2-decenoic acid (C10:1), trans-2-undecenoic acid (C11:1), trans-2-dodecenoicacid (C12:1), trans-2-tridecenoic acid (C13,1), trans-2-tetradecenoic acid (C14:1). The series of compds. I and II listed in Table I were synthesized as described previously)) Carrageenin-Induced Paw Edema Male SD rats (purchased from Japan Keari Co.) weighing 150-170 g were fasted for 24 h prior to experiments but were allowed water ad libitum. Carrageenin (Picnin-A, Zushikagaku)was suspended in 0.9% NaC1 to make a 1.5% (w/v) suspension. The right hind paws were inoculated with 0.1 ml of the prepared carrageenin suspension while the left hind paws were injected with saline. At the indicated times,the volume of the swelling paws was measured by dipping the paws in mercury. The difference in volume between the carrageenin-inoculated and saline-injected paws was recorded as the amount of edema, and the swelling (percent) was calculated on the basis of the volume of the saline-injected paws. Samples were suspended in 5% acacia and were given intraperitoneally 30 min or orally 1 h before the carrageenin injection. Acacia was used as the control. As a positive control, a non-steroidal anti-inflammatory agent, phenylbutazone (Sigma) was given orally. Student's t-test was employed to assess the significance of differences between the mean values for the control group and the sample-administered groups. To evaluate the comparative activity of test samples in independent experiments, the mean inhibition rate (percent) of each sample from the control in the swelling (percent) values at 3,4 and 5 h (when the swelling (percent) value was highest in most cases) after the carrageenin injection was used.
Results

Effect of Intraperitoneally Administered Sulfur-Containing Amino Acids and Amines, and 2-trans Unsaturated Fatty Acids
The effect of intraperitoneally administered sulfur-containing amino acids and amines on the carrageenin-induced paw edema in rats is summarized in Table II . As shown in Table II , cystine, cystamine and ethionine given at a dose of 25 mg/kg showed significant inhibition, and the mean inhibition rates were 25.6, 22.2 and 13.1 %, respectively. However, cysteine, cysteamine, methionine, methionine sulfone and lanthionine had no inhibitory activity. The effects of 2-trans unsaturated fatty acids with various alkene chains on the edema formation are summarized in Table III . 2-trans unsaturated fatty acids with carbon numbers of 7, 8, 9, 13 and 14 had significant inhibitory activity at a dose of 25 mg/kg. In particular, C9 :1 and C13 :1 showed higher mean inhibition rates of 20.0 and 21.2 respectively.
Effect of Intraperitoneal Administration
The series of compds. I and II (Table I) were administered intraperitoneally at a dose of 25 mg/kg, and the effect on carrageenin-induced paw edema was examined. As shown in Table  IV , compds. 1-2, 1-3, 1-4, 1-7, 1-8, 1-9, 11-3, 11-4, 11-5, 11-7, 11-8 and 11-9 had significant inhibitory activity on the edema formation. As to the structure (carbon number)-activity relationship judged from the mean inhibition rates, the compounds (compds. 1-3, 1-8, 11-3 and 11-8) with carbon numbers of 8 and 13 showed the highest inhibitory activity in both series. The mean inhibition rates were 30 50%, and these compounds were much more potent than the starting materials.
Effect of Oral Administration
The effect of orally administered starting materials and compds. 1-3, 1-8, 11-3 and 11-8 on the edema formation was examined, and the results are shown in Table V 
TABLE III. Effect of 2-trans Unsaturated
Fatty Acids on Carrageenin-Induced Paw Edema in Rats a) Each sample was administered at 25 mg/kg intraperitoneally 30 min prior to carrageenin injection. b) All values represent mean + S.E. (n=8). c) Mean inhibition rate of each sample from the control in the swelling (%) value at 3, 4 and 5h after carrageenin injection. Significantly different from the control group: d) p < 0.05, e) p < 0.01. no effect at a dose of 25 mg/kg. Cystamine required a dose of 100 mg/kg to inhibit the edema formation significantly. The fatty acid C8 :1 had no inhibitory activity even at 100 mg/kg p.o., while C13 :I showed significant inhibition at 50 mg/kg p.o. Thus, the activities of the starting materials were influenced by the administration route. On the other hand, compds. 1-3, 1-8, 11-3 and 11-8 were also effective when administered orally (Table VI) . Compounds 1-3 and 11-3 caused significant inhibition at 10 and 25 mg/kg p.o.; their activities were dose-dependent in the range of 5 to 25 mg/kg and were much more potent than those of the starting materials. However, the effects of compds. 1-8 and 11-8 were not dose-dependent. Phenylbutazone, used as a positive control, greatly inhibited the edema formation at a dose of 200 mg/kg, p.o.
Discussion
We have reported that among various sulfur-containing amino acids, cystine and cystamine (with a disulfide bond) had ulceration-inhibitory activity, but the reduced forms of these compounds, cysteine and cysteamine, were ineffective." Furthermore, S-alkyl analogues of cysteamine were found to be potent ulceration inhibitors." It is known that cystamine shows radioprotective21 and gastric mucosal defense3) effects, and that sulfur-containing compounds such as D-penicillamine and SA-96 have anti-rheumatic action.4) Thus, cys- teamine and cystamine derivatives may have anti-inflammatory effects. In a preliminary experiment, we screened sulfur-containing amino acids and amines for anti-inflammatory activity by using the carrageenin-induced paw edema model in rats. It was found that cystamine and cystine had potent anti-edema activity. We next examined the effect of cystamine derivatives, 2-(E-2-alkenoylamino)ethyl disulfides (compds. I), and 2-(E-2-alkenoylamino)ethyl carbamoylmethyl sulfides (compds. II), on the carrageenin-induced paw edema in rats. Among compds. I and II, compds. 1-3, 1-8, 11-3 and 11-8 had stronger inhibitory effects at 25 mg/kg i.p. than the starting materials. The highest anti-edema activity was found with the compounds having carbon numbers of 8 and 13. Compounds 1-3 and 11-3 (with a carbon number of 8) showed dose-dependent inhibition, but compds. 1-8 and 11-8 (with a carbon number of 13) did not. The anti-edema activities of compds. 1-3 and 11-3 were also observed after oral administration. The difference of administration route had no effect on the pharmacological activities, which were characteristically different from those of the starting materials. It was clear that the potent anti-edema activities of compds. 1-3 and 11-3 were due at least partly to the amide bond.
According to Vineger et al.51 and Di Rosa and Willoughby,6) carrageenin-induced paw edema can be classified int() three phases which are mediated by histamine and serotonin (first phase), kinin (second phase) and prostaglandins (PGs, third phase). Since the series of compds. I and II inhibited mainly the second and third phases of carrageenin-induced paw edema, their action mechanism may be related to the metabolism of kinins and PGs. It is well known that most non-steroidal anti-inflammatory agents which act on the metabolism of PGs have the side effect of gastrointestinal damage.') This is because PGs cause increased vascular permeability in inflammation8) while inhibiting gastric juice secretion.91 From this point of view, compds. 1-3 and 11-3 may be superior as anti-edema compounds, since compds. I and II inhibit gastric juice secretion."
